These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 35382760)
1. Treatment of post-transplant recurrent FSGS in children using plasmapheresis and augmentation of immunosuppression. Restrepo JM; Torres-Canchala L; Londoño H; Manzi E; Somers MJG BMC Nephrol; 2022 Apr; 23(1):131. PubMed ID: 35382760 [TBL] [Abstract][Full Text] [Related]
2. Successful Treatment of Focal Segmental Glomerulosclerosis Recurrence in a Second Kidney Transplant Patient: A Case Report. Argiolas D; Carta E; Mascia G; Michittu MB; Piredda GB Transplant Proc; 2019; 51(1):223-225. PubMed ID: 30580884 [TBL] [Abstract][Full Text] [Related]
3. Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children. Dall'Amico R; Ghiggeri G; Carraro M; Artero M; Ghio L; Zamorani E; Zennaro C; Basile G; Montini G; Rivabella L; Cardillo M; Scalamogna M; Ginevri F Am J Kidney Dis; 1999 Dec; 34(6):1048-55. PubMed ID: 10585314 [TBL] [Abstract][Full Text] [Related]
4. Success with plasmapheresis treatment for recurrent focal segmental glomerulosclerosis in pediatric renal transplant recipients. Straatmann C; Kallash M; Killackey M; Iorember F; Aviles D; Bamgbola O; Carson T; Florman S; Vehaskari MV Pediatr Transplant; 2014 Feb; 18(1):29-34. PubMed ID: 24266922 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of intravenous combined immunosuppression with plasmapheresis in adult patients with refractory primary focal segmental glomerulosclerosis. Dirim AB; Demir E; Guller N; Safak S; Artan AS; Oto OA; Ozluk Y; Ozturk S; Yazici H; Kalayoglu-Besisik S; Turkmen A J Clin Apher; 2022 Aug; 37(4):376-387. PubMed ID: 35535432 [TBL] [Abstract][Full Text] [Related]
6. The effect of peri-transplant plasmapheresis in the prevention of recurrent FSGS. Verghese PS; Rheault MN; Jackson S; Matas AJ; Chinnakotla S; Chavers B Pediatr Transplant; 2018 May; 22(3):e13154. PubMed ID: 29388290 [TBL] [Abstract][Full Text] [Related]
7. Immunoadsorption for Recurrent Primary Focal Segmental Glomerulosclerosis on Kidney Allografts: A Single-Center Experience and Literature Review. Naciri Bennani H; Bonzi JY; Noble J; Terrec F; Motte L; Imerzoukene F; Bugnazet M; Giovannini D; Janbon B; Malvezzi P; Rostaing L; Jouve T Blood Purif; 2020; 49(3):322-333. PubMed ID: 31913143 [TBL] [Abstract][Full Text] [Related]
8. Treatment by immunoadsorption for recurrent focal segmental glomerulosclerosis after paediatric kidney transplantation: a multicentre French cohort. Allard L; Kwon T; Krid S; Bacchetta J; Garnier A; Novo R; Deschenes G; Salomon R; Roussey G; Allain-Launay E Nephrol Dial Transplant; 2018 Jun; 33(6):954-963. PubMed ID: 28992235 [TBL] [Abstract][Full Text] [Related]
9. Recurrent focal segmental glomerulosclerosis in the renal allograft: single center experience in the era of modern immunosuppression. Schachter ME; Monahan M; Radhakrishnan J; Crew J; Pollak M; Ratner L; Valeri AM; Stokes MB; Appel GB Clin Nephrol; 2010 Sep; 74(3):173-81. PubMed ID: 20860901 [TBL] [Abstract][Full Text] [Related]
11. Recurrence of nephrotic proteinuria in children with focal segmental glomerulosclerosis: early treatment with plasmapheresis and immunoadsorption should be associated with better prognosis. Fencl F; Vondrák K; Rosík T; Zieg J; Chadimová M; Háček J; Dušek J; Seeman T Minerva Pediatr; 2016 Oct; 68(5):348-54. PubMed ID: 26041001 [TBL] [Abstract][Full Text] [Related]